Turning Genomic Insights into Breakthrough Therapies | Peter Campbell, CSO of Quotient Therapeutics
A conversation with Dr. Campbell, CSO of Quotient Therapeutics
Anastasia Janas
Check out the latest posts
The unsolved frontier: making the undruggable druggable | Eswar Iyer, Aikium
A conversation with Eswar Iyer, CEO & co-founder of Aikium
Reinventing R&D: collaborating for tomorrow’s therapies | Dr. Uli Stilz, Bio Innovation Hub at Novo Nordisk
A conversation with Dr. Uli Stilz, Head of Bio Innovation Hub at Novo Nordisk.
If you’re not too early, you’re too late | Shelby Newsad, Partner at Compound VC
A conversation with Shelby Newsad PhD, Partner at Compound.
Rewriting Genetic Medicine with Epigenetic Editing | Dr. Catherine Stehman-Breen, former CEO of Chroma Medicine
A conversation with Dr. Catherine Stehman-Breen, former CEO of Chroma Medicine.
Unlocking the power of the gut microbiome with AI
A conversation with Leo Grady PhD, founder and CEO of Jona.